Home › Trial NCT00147901
Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)
- Trial IDNCT00147901
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorGerman CLL Study Group
- Enrollment61
- Start date2005-01
- ConditionsB-cell Chronic Lymphocytic Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.